GNRH1 and ovarian hyperstimulation syndrome: In the present study, only 11.3% (95% CI 8.3%-15.0%) (40/353) of high risk patients receiving hCG developed severe OHSS and required the intervention (i.e. GnRH antagonist administration and cryopreservation of all embryos).